NCT06078566: An ongoing trial by Auregen Biotherapeutics, SA
This trial is ongoing. It must report results 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06078566 |
|---|---|
| Title | Long-Term Follow-Up Study of Unilateral Microtia Patients Who Participated in Study AUR 201 05 and Had the AUR-201 Implant in Place at Final Visit (24 Weeks After the First Implantation Surgery) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 26, 2024 |
| Completion date | Nov. 14, 2025 |
| Required reporting date | Nov. 14, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |